(2R)-2-amino-3-phenyl-N-[4-(4-pyridinyl)phenyl]propanamide | 928320-64-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2R)-2-amino-3-phenyl-N-[4-(4-pyridinyl)phenyl]propanamide
• 英文别名: (2R)-2-amino-3-phenyl-N-(4-pyridin-4-ylphenyl)propanamide
• CAS: 928320-64-3
• 化学式: C₂₀H₁₉N₃O
• 分子量: 317.39
• InChiKey: JJTMGYQMWHACOI-LJQANCHMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  68
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  聚合甲醛 、 (2R)-2-amino-3-phenyl-N-[4-(4-pyridinyl)phenyl]propanamide 在 palladium 10% on activated carbon 氢气 作用下， 以 甲醇 为溶剂， 反应 5.0h， 生成 N-α,N-α-dimethyl-N-[4-(4-pyridinyl)phenyl]-D-phenylalaninamide
  参考文献：
  名称：

  WO2007/26920

  摘要：

  公开号：

文献信息

• AMIDE DERIVATIVES AS ROCK INHIBITORS
  申请人：Sawada Kouzo

  公开号：US20090105231A1

  公开（公告）日：2009-04-23

  This invention relates to novel amide derivatives and salts thereof. More particularly, it relates to novel amide derivatives and salts thereof which act as a ROCK inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of ROCK-related disease.

  本发明涉及新型酰胺衍生物及其盐。更具体地说，涉及一种作为ROCK抑制剂的新型酰胺衍生物及其盐，以及包含其的制药组合物和在治疗和/或预防ROCK相关疾病方面的治疗方法。
• METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
  申请人：Navratil Tomas

  公开号：US20090325958A1

  公开（公告）日：2009-12-31

  This invention is directed to methods of preventing or treating diseases or conditions of the lungs associated with excessive cell proliferation, remodeling, inflammation, vasoconstriction, bronchoconstriction, airway hyperreactivity and edema. Particularly, this invention is directed to methods of treating pulmonary diseases such as asthma; chronic obstructive pulmonary disease; respiratory tract illness caused by respiratory syncytial virus; pulmonary arterial hypertension; acute respiratory distress syndrome and ventilator induced lung injury; cystic fibrosis; bronchiectasis; alpha-1-antitrypsin deficiency; rhinitis; rhinosinusitis; primary ciliary dyskinesia; pneumonia; bronchiolitis caused by agents other than respiratory syncytial virus; and interstitial lung disease including lymphangioleiomyomatosis; idiopathic pulmonary fibrosis; obliterative bronchiolitis or bronchiolitis obliterans organizing pneumonia due to lung transplantation or HSCT; nonspecific interstitial pneumonia; cryptogenic organizing pneumonia; acute interstitial pneumonia; respiratory bronchiolitis-associated interstitial lung disease; or pulmonary sarcoidosis. The method comprises administering to a subject an effective amount of a rho kinase inhibitor compound to treat the disease.
• US8211919B2
  申请人：——

  公开号：US8211919B2

  公开（公告）日：2012-07-03
• US8299096B2
  申请人：——

  公开号：US8299096B2

  公开（公告）日：2012-10-30
• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES
  申请人：ASTELLAS PHARMA INC

  公开号：WO2007026920A2

  公开（公告）日：2007-03-08

  [EN] This invention relates to novel amide derivatives and salts thereof. More particularly, it relates to novel amide derivatives and salts thereof which act as a ROCK inhibitor, to a pharmaceutical composition comprising the same and to a method of using the same therapeutically in the treatment and/or prevention of ROCK-related disease.
  [FR] La présente invention concerne de nouveaux dérivés d'amide et les sels de ces derniers et concerne plus particulièrement de nouveaux dérivés d'amide ainsi que leurs sels qui agissent en tant qu'inhibiteur de ROCK, une composition pharmaceutique comprenant ces derniers et une méthode d'utilisation de cette dernière à des fins thérapeutiques dans le traitement et/ou la prévention des maladies associées à ROCK.